| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |